Transactions: Healthcare
Filter
Directed new share issue in Nordic Nanovector ASA (NO) — NOK 250 million
Private placement in Occlutech Holding AG (CH) — SEK 450 million
Rights issue in Targovax ASA (NO) — NOK 175 million
Directed new share issue in Paxman AB — SEK 77 million
Acquisition of Medrave Software AB (SE) by Carasent ASA (NO) — SEK 125 million
Directed share issue in NOVELDA AS (NO) — NOK 400 million
Initial public offering of Devyser Diagnostics AB (SE) on Nasdaq First North Premier Growth Market
Directed share issue in XVIVO Perfusion AB (SE) — SEK 250 million
Directed share issue in Ultimovacs ASA (NO) — NOK 270 million
Directed share issue in Lifecare AS (NO) — NOK 26 million